Table V.
Surfactant activity of commercial Survanta® and l-leucine containing Survanta EEG powder (values are mean (standard deviation), n=3).
Formulation | Surface age (s) |
Final Surface Tension (mN/m) |
Surface tension reduction rate (mN/m/s) |
---|---|---|---|
Survanta® | 59.0 (13.1) | 29.9 (5.5) | 0.73 (0.16) |
L-leucine-Survanta EEG | 65.6 (1.3) | 33.0 (1.5) | 0.58 (0.07) |